Kaken Pharmaceutical Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 6/6
Kaken Pharmaceutical has a total shareholder equity of ¥142.5B and total debt of ¥3.9B, which brings its debt-to-equity ratio to 2.7%. Its total assets and total liabilities are ¥174.8B and ¥32.3B respectively. Kaken Pharmaceutical's EBIT is ¥9.0B making its interest coverage ratio -17.9. It has cash and short-term investments of ¥66.6B.
Anahtar bilgiler
2.7%
Borç/özkaynak oranı
JP¥3.85b
Borç
| Faiz karşılama oranı | -17.9x |
| Nakit | JP¥66.56b |
| Eşitlik | JP¥142.52b |
| Toplam yükümlülükler | JP¥32.26b |
| Toplam varlıklar | JP¥174.78b |
Son finansal sağlık güncellemeleri
Güncelleme yok
Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 4521's short term assets (¥109.1B) exceed its short term liabilities (¥23.1B).
Uzun Vadeli Yükümlülükler: 4521's short term assets (¥109.1B) exceed its long term liabilities (¥9.2B).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 4521 has more cash than its total debt.
Borcun Azaltılması: 4521's debt to equity ratio has reduced from 3.2% to 2.7% over the past 5 years.
Borç Kapsamı: 4521's debt is well covered by operating cash flow (66.9%).
Faiz Kapsamı: 4521 earns more interest than it pays, so coverage of interest payments is not a concern.